
LCTX Market Capitalization Overview
Market Cap: $185.09M as of Jun 13, 2025
$185.09M
Past Month+$77.65M (72.26%)
As of Jun 13, 2025, LCTX has a market capitalization of $185.09M. Over the past 30 days, its market cap has increased by 31.94%, while in the last 12 months, it has increased by 67.1%.
Market capitalization represents the total value of Lineage Cell Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
LCTX Market Cap Formula = Stock Price * Shares Outstanding
The market cap of LCTX helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Lineage Cell Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
LCTX Market Cap Formula = Stock Price * Shares Outstanding
The market cap of LCTX helps investors assess the company's size and compare it with competitors for better investment decisions.
LCTX Market Cap & Key Trends
See Lineage Cell Therapeutics Inc’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in LCTX
Order type
Buy in
Order amount
Est. shares
0 shares
LCTX Market Cap History
Date | Market Cap | Change |
---|---|---|
Jun 2, 2025 | $151.86M | +31.94% |
May 1, 2025 | $115.10M | +22.63% |
Apr 1, 2025 | $93.86M | -16.53% |
Mar 3, 2025 | $112.44M | -26.02% |
Feb 3, 2025 | $151.98M | +33.88% |
Jan 2, 2025 | $113.52M | +2.13% |
LCTX End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $185.09M | +67.10% |
2024 | $110.76M | -41.93% |
2023 | $190.74M | -4.09% |
2022 | $198.88M | -51.84% |
2021 | $412.97M | +56.44% |
2020 | $263.99M | — |
FAQs About Lineage Cell Therapeutics Inc (LCTX) Market Cap
As of Jun 13, 2025, the market capitalization of LCTX is $185.09M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Lineage Cell Therapeutics Inc’s market capitalization has increased by 72.26%, changing from $107.45M to $185.09M as of Jun 13, 2025.
In the last 3 months, Lineage Cell Therapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, Lineage Cell Therapeutics Inc’s market capitalization decreased from $190.74M in January to $110.76M in December, reflecting a -41.93% change.
In the past five years, LCTX has had a compound annual growth rate (CAGR) of -15.95% in market capitalization. This means its market cap has shrunk at an average rate of -15.95% per year.